Comparison between Avience Biomedicals IPO and N R Vandana Tex Industries IPO.
Avience Biomedicals IPO is a SME Bookbuilding IPO proposed to list at NSE SME while N R Vandana Tex Industries IPO is a SME Bookbuilding proposed to list at NSE SME.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Fintellectual Corporate Advisors Pvt.Ltd. | Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Asnani Stock Broker Pvt.Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Avience Biomedicals IPO is up to ₹0.00 Cr whereas the issue size of the N R Vandana Tex Industries IPO is up to ₹26.49 Cr. The final issue price of Avience Biomedicals IPO is and of N R Vandana Tex Industries IPO is ₹45.00 per share.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹42.00 per share | |
| Issue Price (Upper) | ₹45.00 per share | |
| Issue Price (Final) | ₹45.00 per share | |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 15,27,600 shares | 58,86,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹26.49 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 15,27,600 shares | 58,86,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹26.49 Cr |
Avience Biomedicals IPO opens on , while N R Vandana Tex Industries IPO opens on May 28, 2025. The closing date of Avience Biomedicals IPO and N R Vandana Tex Industries IPO is , and May 30, 2025, respectively.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | |
|---|---|---|
| Anchor Bid Date | May 27, 2025 | |
| Issue Open | May 28, 2025 | |
| Issue Close | May 30, 2025 | |
| Basis Of Allotment (Tentative) | Jun 02, 2025 | |
| Initiation of Refunds (Tentative) | Jun 03, 2025 | |
| Credit of Share (Tentative) | Jun 03, 2025 | |
| Listing date (Tentative) | Jun 04, 2025 | |
| Anchor Lockin End date 1 | Jul 02, 2025 | |
| Anchor Lockin End date 2 | Aug 31, 2025 |
Avience Biomedicals IPO P/E ratio is , as compared to N R Vandana Tex Industries IPO P/E ratio of 8.95.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Avience Biomedicals Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 239% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)N R Vandana Tex Industries Ltd.'s revenue increased by 23% and profit after tax (PAT) rose by 100% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.85 | 100 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.37 | 73.39 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 8.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹104.83 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 50.14 | 17.54 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.84 | 13.82 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.97 | 2.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.03 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 50.14 | 15.10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Avience Biomedicals IPO Retail Individual Investors (RII) are offered 0 shares while in N R Vandana Tex Industries IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Avience Biomedicals IPO and 11,76,000 shares in N R Vandana Tex Industries IPO.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 17,61,000 shares | |
| Market Maker Reservation | 80,400 shares | 3,12,000 shares |
| QIB | 0 shares | 11,76,000 shares |
| NII | 0 shares | 8,85,000 shares |
| RII | 0 shares | 20,64,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 0 shares | 58,86,000 shares |
Avience Biomedicals IPO subscribed in total, whereas N R Vandana Tex Industries IPO subscribed 101.00x.
| Avience Biomedicals IPO | N R Vandana Tex Industries IPO | |
|---|---|---|
| QIB (times) | 36.54x | |
| NII (times) | 126.70x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 101.00x |
